125 related articles for article (PubMed ID: 12021274)
41. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.
Pepper MS; Baetens D; Mandriota SJ; Di Sanza C; Oikemus S; Lane TF; Soriano JV; Montesano R; Iruela-Arispe ML
Dev Dyn; 2000 Jul; 218(3):507-24. PubMed ID: 10878616
[TBL] [Abstract][Full Text] [Related]
42. Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis.
McTigue MA; Wickersham JA; Pinko C; Showalter RE; Parast CV; Tempczyk-Russell A; Gehring MR; Mroczkowski B; Kan CC; Villafranca JE; Appelt K
Structure; 1999 Mar; 7(3):319-30. PubMed ID: 10368301
[TBL] [Abstract][Full Text] [Related]
43. Vascular endothelial growth factor and its receptors.
Neufeld G; Tessler S; Gitay-Goren H; Cohen T; Levi BZ
Prog Growth Factor Res; 1994; 5(1):89-97. PubMed ID: 7515293
[TBL] [Abstract][Full Text] [Related]
44. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
45. A new tyrosine-specific chymotrypsin-like and angiotensin-degrading serine proteinase from Vipera lebetina snake venom.
Siigur E; Tõnismägi K; Trummal K; Samel M; Vija H; Aaspõllu A; Rönnholm G; Subbi J; Kalkkinen N; Siigur J
Biochimie; 2011 Feb; 93(2):321-30. PubMed ID: 20950666
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
47. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.
Saaristo A; Veikkola T; Enholm B; Hytönen M; Arola J; Pajusola K; Turunen P; Jeltsch M; Karkkainen MJ; Kerjaschki D; Bueler H; Ylä-Herttuala S; Alitalo K
FASEB J; 2002 Jul; 16(9):1041-9. PubMed ID: 12087065
[TBL] [Abstract][Full Text] [Related]
48. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2).
Yamazaki Y; Takani K; Atoda H; Morita T
J Biol Chem; 2003 Dec; 278(52):51985-8. PubMed ID: 14600159
[TBL] [Abstract][Full Text] [Related]
49. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.
Zhu Z; Lu D; Kotanides H; Santiago A; Jimenez X; Simcox T; Hicklin DJ; Bohlen P; Witte L
Cancer Lett; 1999 Mar; 136(2):203-13. PubMed ID: 10355750
[TBL] [Abstract][Full Text] [Related]
51. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways.
Zeng H; Dvorak HF; Mukhopadhyay D
J Biol Chem; 2001 Jul; 276(29):26969-79. PubMed ID: 11350975
[TBL] [Abstract][Full Text] [Related]
52. Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells.
Shen BQ; Lee DY; Cortopassi KM; Damico LA; Zioncheck TF
J Biol Chem; 2001 Feb; 276(7):5281-6. PubMed ID: 11058594
[TBL] [Abstract][Full Text] [Related]
53. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF.
Wang D; Donner DB; Warren RS
J Biol Chem; 2000 May; 275(21):15905-11. PubMed ID: 10748050
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
[TBL] [Abstract][Full Text] [Related]
55. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway.
Hata Y; Rook SL; Aiello LP
Diabetes; 1999 May; 48(5):1145-55. PubMed ID: 10331422
[TBL] [Abstract][Full Text] [Related]
56. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
[TBL] [Abstract][Full Text] [Related]
57. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.
Mohammadi M; Froum S; Hamby JM; Schroeder MC; Panek RL; Lu GH; Eliseenkova AV; Green D; Schlessinger J; Hubbard SR
EMBO J; 1998 Oct; 17(20):5896-904. PubMed ID: 9774334
[TBL] [Abstract][Full Text] [Related]
58. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
Morbidelli L; Pyriochou A; Filippi S; Vasileiadis I; Roussos C; Zhou Z; Loutrari H; Waltenberger J; Stössel A; Giannis A; Ziche M; Papapetropoulos A
Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R824-32. PubMed ID: 20032260
[TBL] [Abstract][Full Text] [Related]
59. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165.
Yamazaki Y; Tokunaga Y; Takani K; Morita T
Biochemistry; 2005 Jun; 44(24):8858-64. PubMed ID: 15952792
[TBL] [Abstract][Full Text] [Related]
60. Molecular cloning and expression of a functional snake venom vascular endothelium growth factor (VEGF) from the Bothrops insularis pit viper. A new member of the VEGF family of proteins.
Junqueira de Azevedo IL; Farsky SH; Oliveira ML; Ho PL
J Biol Chem; 2001 Oct; 276(43):39836-42. PubMed ID: 11517227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
